Literature DB >> 32007506

Critical Analysis of Hepatic Clearance Based on an Advection Mass Transfer Model and Mass Balance.

Gregory M Kochak1.   

Abstract

The relationship between liver blood flow rate and hepatic clearance has been derived and validated based on the constitutive principle of mass conservation using an advective mass transfer model for bivariate concentration, Ci (x, t). Metabolic elimination continuously diminishes along the blood flow path line, corresponding with the concentration gradient. Because of the constraint introduced by constant blood velocity, x and t are not independent variables. This requires the introduction of a new factor called the dwell time, which accounts for the time a drug is retained in the liver. First-order or saturable drug metabolism is dependent on perfusate drug concentration and the dwell time. A new extraction factor is explicitly identified as E = ln Cin/Cout. Because the isolated organ perfusion model described here is validated, it provides a basis for drawing inferences and exploring underlying features, mechanisms, and principles on which this model is based. In the conventional model, these underlying constitutive principles are unavailable. The concentration-time profile of a physiological-based elimination network is found to be inconsistent with the profile described by a pharmacokinetic model. For this reason, among others discussed, physiological-based models are incompatible with pharmacokinetic models and therefore cannot be used to explain systemic pharmacokinetic behavior.
Copyright © 2020 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  blood flow; computational ADME; drug transport; first-pass metabolism; hepatic clearance; hepatic metabolism; hepatic transport; pharmacokinetics

Mesh:

Year:  2020        PMID: 32007506     DOI: 10.1016/j.xphs.2020.01.024

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  2 in total

1.  Effect of autoinduction and food on the pharmacokinetics of furmonertinib and its active metabolite characterized by a population pharmacokinetic model.

Authors:  Hui-Xi Zou; Yu-Feng Zhang; Da-Fang Zhong; Yong Jiang; Fei Liu; Qian-Yu Zhao; Zhong Zuo; Yi-Fan Zhang; Xiao-Yu Yan
Journal:  Acta Pharmacol Sin       Date:  2021-11-17       Impact factor: 7.169

Review 2.  Can In Vitro-In Vivo Extrapolation Be Successful? Recognizing the Incorrect Clearance Assumptions.

Authors:  Leslie Z Benet; Jasleen K Sodhi
Journal:  Clin Pharmacol Ther       Date:  2021-12-08       Impact factor: 6.903

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.